Medtronic to Buy Contego Medical for $380 Million, Days After FDA Approves Its Carotid System
Medtronic plans to buy Contego Medical for $380 million plus undisclosed contingent payments. The deal adds a carotid stenting system with a built-in filter that the FDA approved days earlier, setting up direct competition with Boston Scientific in the growing field of transcarotid revascularization.